Merck & Co., Inc. (MRK) Earnings
NYSE·Healthcare·Drug Manufacturers - General
$150.05
+2.51%
Mkt Cap $346.91B
Just Reported
Q2 2026YesterdayThu, Oct 29, 2026
EPS
$2.49
vs $2.41 est
+3.32%
Revenue
$18.09B
vs $17.57B est
+2.93%
EPS — Estimate vs Actual
Mkt Cap
$346.91B
P/E
42.27
Fwd P/E
12.81
P/S
5.27
Rev TTM
—
EPS TTM
$3.55